Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-06

Clinical Trial Update: Safety of Sofosbuvir in People With Advanced Kidney Failure [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update assessing the safety of Sofosbuvir in people with advanced kidney failure and chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Sanjay Gandhi Postgraduate Institute of Medical Sciences | Conditions: Kidney Failure, Chronic, Hepatitis C | Phase 3 | Status: COMPLETED